A fast start to 2026 signals continued investor confidence i...
Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.
Newsletters and Deep Dive digital magazine
Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.
One important way that pharma companies can deliver true patient advocacy is by bringing cross-functional experience to the table.
The pharmaceutical services sector saw a flurry of new executive hires last month, spanning agencies, consultancies, investment firms & a few others.
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
Editor's Picks
Newsletters and Deep Dive
digital magazine